International Society of Blood Transfusion
@isbt.bsky.social
Connecting transfusion medicine professionals worldwide since 1935! 🌍 ISBT unites experts from 100+ countries to advance science, share knowledge, and drive innovation and best practices across the transfusion chain.
New on #TransfusionToday, Nikasha Williams, Milan Shah, Mahsa Yazdanbakhsh, and Jason Acker map the shift toward direct, single-cell RBC assessment — from FlowScore and AI-driven morphology imaging to deformability cytometry and single-cell oxygen-exchange kinetics isbtweb.foleon.com/transfusion-...
Towards Better Analytical Tools for Blood Quality Assessment - July 2026 - Transfusion Today
isbtweb.foleon.com
📢 The July issue of #TransfusionToday is out now! This edition focuses on the #BloodComponents Working Party — cold-stored platelets, whole blood for trauma, plasma storage, drone delivery in Africa and more. isbtweb.foleon.com/transfusion-...
Cover - July 2026 - Transfusion Today
isbtweb.foleon.com
🩸 Is your hospital ready for a mass casualty event? Join ISBT's Meet the Expert webinar with Dr Jeremy Cannon (U Penn) — military & civilian trauma surgery insights on MCI preparedness. 📅 23 July 2026, 4-5:30pm CEST www.isbtweb.org/events/isbt-... #TransfusionMedicine #ISBTWebinar
ISBT Webinar: Dr Jeremy Cannon answers your questions about how to prepare your hospital for a mass casualty event
isbtweb.org
New in Vox Sanguinis: Active haemovigilance data on transfusion reactions in paediatric patients from a children's hospital in India. Key risk factors: transfusion history, age, blood component type & indication. 🔗 onlinelibrary.wiley.com/doi/abs/10.1... #Haemovigilance #TransfusionMedicine
Factors influencing transfusion reactions in paediatric patients: Active haemovigilance data from a children's hospital in India
Background and Objectives Because of inherent differences, reports on paediatric transfusion reactions are more heterogeneous than those seen in the adult population. In this study, we aimed to pros...
onlinelibrary.wiley.com
How prepared is your transfusion service for the unexpected? Join us for an interactive webinar with Fateha Chowdhury, who will share insights on emergency preparedness for hospital transfusion teams, covering challenges such as cyber-attacks, blood shortages, power outages, and pandemics.
Recently published in #VoxSanguinis: Our scoping review explores the use of the grey zone (GZ) in transfusion-transmitted infection (TTI) screening among blood donors. doi.org/10.1111/vox....
A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors
Background and Objectives Screening for transfusion-transmitted infections (TTIs) among blood donors is done using qualitative screening assays. Screening values that are close to cut-off values lie.....
doi.org
Recently published in #VoxSanguinis: how AI could transform blood donor management—from improving operational efficiency and predicting donor behaviour to enhancing donor engagement. doi.org/10.1111/vox....
Artificial intelligence in blood donor management: A narrative review
Blood transfusions are vital in health care, yet maintaining an adequate and safe blood supply remains a significant challenge. To address blood donation–associated challenges, this review explores h...
doi.org
#ISBTKualaLumpur – Day 1 Highlights 🌏 From sharing the latest developments to exchanging ideas for the future of the field, Day 1 set the tone for an inspiring week in Kuala Lumpur. Watch the highlights from the opening day 📽️
Come Celebrate the Moment of Giving. Moment of Care. At ISBT 2026. From blood collection to component processing, every step reflects a shared commitment to care made possible by donors and the professionals who support them.
Blood safety threats are not slowing down. But many lab workflows still are. At #ISBTKualaLumpur, the conversation is shifting, from faster systems to smarter performance across the entire workflow.
We are pleased to announce the relaunch of the ICSPP website, supporting access to safe plasma protein therapies in resource-constrained settings. Learn more: www.isbtweb.org/partnerships...
Join the ISBT Corporate Partner Educational Webinar with Terumo BCT: Advancing Toward Non-DEHP Disposables 📅 4 June 2026 🕒 3–4 PM CEST www.isbtweb.org/events/isbt-...
ISBT Corporate Partner Educational Webinar Terumo BCT: Advancing Toward Non‑DEHP Disposables
isbtweb.org
New #TalkingTransfusion episode out now! We explore cutting-edge research in transfusion and stem cell transplantation for thalassaemia—covering novel oral therapies, red cell product innovations, and allogeneic stem cell transplantation. open.spotify.com/episode/0NuY...
Episode 7: International Thalassaemia Day 2026
open.spotify.com
#VoxSanguinis Can machine learning help improve blood donor retention? Our study uses predictive models to analyse donor behaviour and identify what drives people to return. We find that factors like time between donations and donation location are key predictors of donor return rates.
Prediction of blood donor return behaviour using machine learning
Background and Objectives Blood donor return behaviour is frequently examined through questionnaires assessing donors' motivations, attitudes, awareness and willingness to donate. An enhanced donor .....
onlinelibrary.wiley.com
Join the ISBT Corporate Partner Webinar: Use of Artificial Intelligence in Transfusion Medicine Practice, Education and Research 🗓 11 May 2026 ⏰ 15:00–16:30 CEST For scientists, blood bankers & transfusion professionals www.isbtweb.org/events/isbt-...
ISBT Corporate Partner Webinar: Use of artificial intelligence in transfusion medicine practice, education and research
isbtweb.org
Did you miss last week’s webinar with Terumo BCT, “From Vision to Reality: Operationalizing the Digital Blood Center”? Good news—you can now watch it on demand and catch up anytime. www.isbtweb.org/resource/fro...
From vision to reality: Operationalizing the digital blood center
Zheng Yinhong, Oscar Zamudio Chávez, Luis Larrea, Andrew Tang
isbtweb.org
New in #VoxSanguinis The review explores the use of the “grey zone” in transfusion-transmitted infection (TTI) screening among blood donors. doi.org/10.1111/vox....
A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors
Background and Objectives Screening for transfusion-transmitted infections (TTIs) among blood donors is done using qualitative screening assays. Screening values that are close to cut-off values lie...
doi.org
How does the evidence for communication-based interventions to motivate blood donation stack up? Read our new paper to find out…🔓📄 doi.org/10.1111/vox.... @isbt.bsky.social #Transfusion #Blood
The efficacy of interactive communication interventions for motivating blood donation: A systematic review
Background and Objectives The global blood product shortage is a persistent problem that urgently needs addressing. Research has investigated the effects of incentives, different interventions and d...
doi.org
2025 International #PlateletTransfusion Guidelines This update highlights a restrictive, evidence-based approach to platelet transfusion, with decisions guided by clinical context rather than platelet count alone. 📖 doi:10.1001/jama.2025.7529 #PatientBloodManagement
Reminder: Tomorrow’s ISBT Corporate Partner Educational Webinar with Terumo Blood and Cell Technologies From Vision to Reality – Operationalizing the Digital Blood Center 🗓 9 April 2026 | ⏰ 2:00 – 3:15 PM SGT www.isbtweb.org/events/isbt-...
ISBT Corporate Partner Educational Webinar Terumo BCT: From Vision to Reality: Operationalizing the Digital Blood Center
isbtweb.org
India has one of the world’s largest populations with #thalassemia major - a new article in #VoxSanguinis highlights key insights on diagnosis, management, and prevention. Essential reading for healthcare professionals, policymakers, and anyone working in #thalassemiacare 🔗 doi.org/10.1111/vox....
Assessment of services for diagnosis, management and prevention of thalassaemia in India: The way forward
Reader environment loaded
doi.org
Episode 14 of Transfusion Practitioners Across the World is live! Join Rachel Moss as she chats with Lawrance Nyoni about his journey from Zimbabwe → South Africa → UK, and his exciting transition from biomedical science to the world of transfusion practice. open.spotify.com/episode/3UkS...
Episode 14: Exploring the Transfusion Practitioner Role with Rachel Moss & Lawrance Nyoni
Spotify video
open.spotify.com
Recently shared in #VoxSanguinis: Seroprevalence of Hepatitis D Virus among HBsAg-positive blood donors at Yaoundé Central Hospital, Cameroon. The report highlights a high prevalence of HDV in asymptomatic blood donors and shows that anti-HDV detection depends on the HBsAg screening method.
Seroprevalence of hepatitis D virus among blood donors with hepatitis B surface antigen at Yaounde Central Hospital, Cameroon
Background and Objectives Hepatitis delta virus (HDV) superinfection with hepatitis B virus (HBV) infection can cause a severe form of viral hepatitis. A nation-wide general population study in Came...
onlinelibrary.wiley.com
Transform the Digital Blood Center from Vision to Reality Join ISBT and Terumo BCT for a practical webinar on operationalizing digital transformation in blood centers. 📅 9 April 2026 | ⏰ 2:00 – 3:15 PM SGT 💻 Free – Register Now www.isbtweb.org/events/isbt-...
ISBT Corporate Partner Educational Webinar Terumo BCT: From Vision to Reality: Operationalizing the Digital Blood Center
isbtweb.org
Recently published in #VoxSanguinis • Group B or AB platelets/plasma transfused to group O recipients carry a ⬆ risk of severe allergic reactions. • Risk is stronger with platelets than plasma, potentially linked to α-gal syndrome. Use ABO-identical platelets/plasma for group O whenever possible.
Association between group B major ABO‐incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α‐gal syndrome. A Biomedical...
Background and Objectives Severe transfusion reactions to group B–incompatible platelets and plasma possibly related to the α-gal syndrome (AGS) have been recently described. AGS is a potentially se.....
onlinelibrary.wiley.com
Less than 3 months to go until #ISBTKualaLumpur We received an incredible 1,313 abstracts, with a strong programme of oral presentations and posters coming your way. ⚠️ Poster presenters: register by 1 April 💸 Early bird savings end 15 April www.isbtweb.org/events/isbt-...
New in #VoxSanguinis: Brazil’s policy lifting the MSM blood donor deferral didn’t raise HIV, HBV, or HCV rates across 560K+ donations. Syphilis rise in first-time donors mirrors broader trends—public health strategies matter onlinelibrary.wiley.com/doi/abs/10.1... #BloodSafety #PublicHealth
Assessing the effect of policy change on transfusion safety in Brazil: A three‐and‐a‐half‐year study after lifting the deferral for men who have sex with men
Background and Objectives In July 2020, Brazil removed the long-standing restrictions on blood donation by men who have sex with men (MSM), shifting donor eligibility criteria towards individual beh.....
onlinelibrary.wiley.com
1313 abstracts submitted for #ISBTKualaLumpur! 🇲🇾 Reviewing is underway with Malaysian Society of Blood Transfusion & MCI The Netherlands. Topics: Blood Donation, Clinical Transfusion, Cellular Therapies & more. Authors notified from 13 Mar 2026—stay tuned! 📝 #BloodTransfusion
New research in #VoxSanguinis explores low haemoglobin density (LHD%) as a no-added-cost marker for screening iron deficiency. Accessible, scalable, and derived from routine CBC data. 🔗 onlinelibrary.wiley.com/doi/full/10.... #Haematology #IronDeficiency #Anaemia
Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency
Background and Objectives Iron deficiency (ID), with or without anaemia, affects over 1 billion people globally. Early detection is essential, but current diagnostic tools may be costly, logisticall.....
onlinelibrary.wiley.com
#ISBTWebinar: Let’s talk CAR-T cells – heterogeneity, quality control & adverse events Tomorrow | 17:00 CET Join Dr. Salim Oulghazi for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.